Ocular surface epithelial precursors

眼表面上皮前体细胞

基本信息

项目摘要

DESCRIPTION (provided by applicant): Small populations of stem cells sustain the limbal-corneal and the conjunctival lineages. In the limbal-corneal system, where stem cells localize preferentially to the limbus, total or zonal damage produces epithelial limbal stem cell deficiency syndromes. In recent years, a variety of surgical stem cell transplant methodologies have been applied to reestablish the limbal stem cell niche for vision restoration. The long term goals of our studies are a) understand the functional nature of ocular surface stem cells, in particular those of the limbus; and b) apply this critical knowledge for the optimization of ex vivo limbal cell population expansion to improve surface reconstructive procedures based on transplantation of stem cell-rich cell populations. During the initial funding period of this grant we characterized small stem cell cohorts known as side populations (SPs) from both conjunctival and limbal epithelia. Our studies showed that these cells derive from cells that have been in the slow cycling state in vivo and to display several other features recognized for stem cells in vitro. Based on finding during this period we now propose, in Specific Aim1 to test the hypothesis that cell cohorts expressing CD62E or excluding mitotrakcker deep red constitute additional component of an heterogeneous stem/precursor limbal and conjunctival epithelial cell population and in Specific Aim2 to test the hypothesis that observed overexpressions of several genes capable of affecting gene transcription globally and usually referred as master or cell fate genes (PAX6, MEIS1, SIX1, MSX1, HES1 ID1, the MXD1/MAX system controlling MYC activity) contribute to cell stemness in the limbal epithelium. The knowledge acquired in the comparative characterization of the cell cohorts associated with the stem/precursor cell compartment in Aim 1, combined with the identification of gene expressions and signal pathways that are associated with preservation or loss of the stem/precursor cell state in Specific Aim 2, will provide the cogent basis to improve strategies for either maximization of stem/precursor cell yields during limbal cells expansion in vitro, or alternatively, facilitate stem cell rescue from generic proliferative (basal) epithelial cells through reversion of phenotype for the benefit of reconstructive ocular surface procedures. Specific aim 3 seeks to apply the knowledge and expertise acquired in the two previous specific aims for the genetic and/pharmacological manipulation of freshly isolated limbal epithelial cells to attain effective expansion of these cells while maintaining their capacity for corneal epithelial function recovery in vivo. PUBLIC HEALTH RELEVANCE: Damage to the limbus by chemical or thermal injuries, microbial infection, or autoimmune reactions result in limbal stem cell deficiencies (LSCD) causing visual loss and blindness. Transplants with expanded limbal cell populations incorporating stem cells can restore or improve vision. We now propose a roadmap to test the impact of genes identified in these stem cells on their phenotype and survival and to apply the gained insight to increase the content of stem cells in expanded limbal populations and thereby improve the outcome of corneal reconstruction surgeries.
描述(由申请方提供):少量干细胞维持角膜缘-角膜和结膜谱系。在角膜缘-角膜系统中,干细胞优先定位于利姆布斯,全部或带状损伤产生上皮角膜缘干细胞缺乏综合征。近年来,各种外科干细胞移植方法已被应用于重建角膜缘干细胞龛以恢复视力。我们研究的长期目标是a)了解眼表面干细胞的功能性质,特别是利姆布斯的干细胞的功能性质;和B)将该关键知识应用于离体角膜缘细胞群扩增的优化,以改进基于富含干细胞的细胞群的移植的表面重建程序。在该资助的初始资助期间,我们对来自结膜和角膜缘上皮的称为侧群(SP)的小干细胞群进行了表征。我们的研究表明,这些细胞来源于体内处于慢循环状态的细胞,并显示出体外干细胞的其他几个特征。根据这一时期的发现,我们现在提出,在特定目的1中,检验表达CD 62 E或排除mitotrakcker深红色的细胞群构成异质性干细胞的额外组分的假设/前体角膜缘和结膜上皮细胞群和特异性Aim 2,以检验观察到的几种基因过度表达的假设,这些基因能够全面影响基因转录,通常被称为主基因或细胞命运基因(PAX 6、MEIS 1、SIX 1、MSX 1、HES 1 ID 1、控制MYC活性的MXD 1/MAX系统)有助于角膜缘上皮中的细胞干细胞性。在与目标1中的干细胞/前体细胞区室相关的细胞群的比较表征中获得的知识,与特定目标2中与干细胞/前体细胞状态的保存或丧失相关的基因表达和信号通路的鉴定相结合,将为改进在体外角膜缘细胞扩增期间最大化干细胞/前体细胞产量的策略,或者通过表型逆转促进从一般增殖(基底)上皮细胞中拯救干细胞,以利于重建眼表面程序。具体目标3旨在应用在前两个具体目标中获得的知识和专业知识,对新鲜分离的角膜缘上皮细胞进行遗传和/或药理学操作,以实现这些细胞的有效扩增,同时保持其在体内恢复角膜上皮功能的能力。 公共卫生关系:由化学或热损伤、微生物感染或自身免疫反应引起的对利姆布斯的损伤导致角膜缘干细胞缺陷(LSCD),引起视力丧失和失明。含有干细胞的扩增角膜缘细胞群的移植可以恢复或改善视力。我们现在提出了一个路线图,以测试在这些干细胞中识别的基因对其表型和存活的影响,并应用所获得的洞察力来增加干细胞在扩增的角膜缘群体中的含量,从而改善角膜重建手术的结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSE MARIO WOLOSIN其他文献

JOSE MARIO WOLOSIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSE MARIO WOLOSIN', 18)}}的其他基金

ROS and MAPK signal cascades in corneal myofibroblast genesis
角膜肌成纤维细胞发生中的ROS和MAPK信号级联
  • 批准号:
    10179399
  • 财政年份:
    2018
  • 资助金额:
    $ 42.38万
  • 项目类别:
ROS and MAPK signal cascades in corneal myofibroblast genesis
角膜肌成纤维细胞发生中的ROS和MAPK信号级联
  • 批准号:
    9788093
  • 财政年份:
    2018
  • 资助金额:
    $ 42.38万
  • 项目类别:
Ocular surface epithelial precursors
眼表面上皮前体细胞
  • 批准号:
    8624693
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
OCULAR SURFACE EPITHELIAL PRECURSORS
眼表上皮前体
  • 批准号:
    6854180
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
OCULAR SURFACE EPITHELIAL PRECURSORS
眼表面上皮前体
  • 批准号:
    7345367
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
OCULAR SURFACE EPITHELIAL PRECURSORS
眼表面上皮前体
  • 批准号:
    7582256
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
OCULAR SURFACE EPITHELIAL PRECURSORS
眼表上皮前体
  • 批准号:
    7009196
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
Ocular surface epithelial precursors
眼表面上皮前体细胞
  • 批准号:
    8232010
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
Ocular surface epithelial precursors
眼表面上皮前体细胞
  • 批准号:
    8435518
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
OCULAR SURFACE EPITHELIAL PRECURSORS
眼表上皮前体
  • 批准号:
    7176762
  • 财政年份:
    2005
  • 资助金额:
    $ 42.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了